Clinical Trial: Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474077) titled 'Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH' on March 10.

Brief Summary: Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition: Post Partum Haemorrhage

Intervention: DRUG: tranexamic acid (1 g diluted in 100 mL of 0.9% saline

This intervention is currently used for treatment of postpartum hemorr...